Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Volume-regulated anion channels (VRACs) are large-pore channels present in nearly all vertebrate cells, playing key roles in cell volume regulation and autocrine/paracrine signaling. Here, we identify the ubiquitously expressed puromycin-sensitive aminopeptidase (PSA) as a binding partner of the obligatory VRAC subunit SWELL1 (also known as LRRC8A) and report the cryo-electron microscopy structure of the SWELL1-PSA complex. Three PSA molecules associate with a single SWELL1 hexamer, coupling adjacent leucine-rich repeat (LRR) domains into local dimers. Functionally, PSA overexpression suppresses VRAC activation, whereas its deletion results in elevated basal channel activity. Notably, PSA's regulatory role on VRACs is independent of its aminopeptidase activity. Our findings identify PSA as the first auxiliary subunit of VRACs, highlight the role of intracellular LRR domains in allosteric channel gating, and propose a new strategy for modulating VRAC function in diverse physiological contexts, including cGAMP transport and STING signaling.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12407707 | PMC |
| http://dx.doi.org/10.1101/2025.08.24.671966 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Volume-regulated anion channels (VRACs) are large-pore channels present in nearly all vertebrate cells, playing key roles in cell volume regulation and autocrine/paracrine signaling. Here, we identify the ubiquitously expressed puromycin-sensitive aminopeptidase (PSA) as a binding partner of the obligatory VRAC subunit SWELL1 (also known as LRRC8A) and report the cryo-electron microscopy structure of the SWELL1-PSA complex. Three PSA molecules associate with a single SWELL1 hexamer, coupling adjacent leucine-rich repeat (LRR) domains into local dimers.
View Article and Find Full Text PDFRegulation of volume-regulated anion channels alters sensitivity to platinum chemotherapy.
Sci Adv
December 2024
Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Cisplatin-based chemotherapy is used across many common tumor types, but resistance reduces the likelihood of long-term survival. We previously found the puromycin-sensitive aminopeptidase, NPEPPS, as a druggable driver of cisplatin resistance in vitro and in vivo and in patient-derived organoids. Here, we present a general mechanism where NPEPPS interacts with the volume-regulated anion channels (VRACs) to control cisplatin import into cells and thus regulate cisplatin response across a range of cancer types.
View Article and Find Full Text PDFA review of possible biomarkers for opioid tolerance.
Forensic Sci Int
October 2024
Department of Forensic Medicine, Aarhus University, Denmark; Department of Clinical Pharmacology, Aarhus University Hospital, Denmark. Electronic address:
Knowledge of opioid tolerance in a deceased person is important for distinguishing between therapeutic and toxic opioid concentrations for that particular individual when interpreting postmortem toxicological results. However, no biomarkers for opioid tolerance are currently available. This review aimed to study the existing literature on mechanisms or changes in signaling pathways related to chronic opioid use, which could be relevant for further studies to identify biomarkers for opioid tolerance.
View Article and Find Full Text PDFModulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase.
Eur J Med Chem
September 2024
Center for Drug Design, College of Pharmacy, University of Minnesota, MN, USA. Electronic address:
Article Synopsis
- The endogenous opioid system helps regulate pain through the release of neuropeptides, but opioid peptides like enkephalins are quickly broken down by enzymes, limiting their effectiveness.
- A novel approach to manage pain involves developing inhibitors that prevent the breakdown of enkephalins, with previous studies identifying a promising compound that needs refinement to avoid toxic side effects.
- The new compound improved pain relief and showed strong interaction with opioid receptors, while further research indicated it has good stability in the body and supports the continued development of these inhibitors for better pain management.
Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase.
Discov Oncol
May 2024
Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
Breast cancer is a prevalent malignant tumor among women with an increasing incidence rate annually. Breast cancer stem cells (BCSCs) are integral in impeding tumor advancement and addressing drug resistance. Bestatin serves as an adjuvant chemotherapy, triggering apoptosis in cancer cells.
View Article and Find Full Text PDF